Detalhe da pesquisa
1.
Tolfenamic Acid Derivatives: A New Class of Transcriptional Modulators with Potential Therapeutic Applications for Alzheimer's Disease and Related Disorders.
Int J Mol Sci
; 24(20)2023 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37894896
2.
Altered microRNA, mRNA, and Protein Expression of Neurodegeneration-Related Biomarkers and Their Transcriptional and Epigenetic Modifiers in a Human Tau Transgenic Mouse Model in Response to Developmental Lead Exposure.
J Alzheimers Dis
; 63(1): 273-282, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29614648
3.
Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy.
Curr Alzheimer Res
; 15(7): 655-663, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29357795
4.
Early-Life Exposure to Lead (Pb) Alters the Expression of microRNA that Target Proteins Associated with Alzheimer's Disease.
J Alzheimers Dis
; 51(4): 1257-64, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26923026
5.
Loss in efficacy measures of tolfenamic acid in a tau knock-out model: Relevance to Alzheimer's disease.
Exp Biol Med (Maywood)
; 244(13): 1062-1069, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31450960